Esoxybutynin

Esoxybutynin

SCHEMBL5690091

CCN(CC)CC#CCOC(=O)[C@@](O)(c1ccccc1)C1CCCCC1.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM2CHRM3

The experimentally established mechanism targets of Esoxybutynin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 6/20 0.98
CHRM3 known ✓ P20309 4/20 0.98
MEN1 O00255 1/20 1.00
RECQL P46063 1/20 1.00
PMP22 Q01453 1/20 1.00
KMT2A Q03164 1/20 1.00
NPSR1 Q6W5P4 1/20 1.00
CHRM1 P11229 6/20 0.98
CHRM4 P08173 4/20 0.98
KCNH2 Q12809 3/20 0.98
CYP2C19 P33261 2/20 0.98
SLC6A3 Q01959 2/20 0.98
CYP3A4 P08684 2/20 0.98
CYP1A2 P05177 1/20 0.98
CYP2D6 P10635 1/20 0.98
CYP2C9 P11712 1/20 0.98
PKM P14618 1/20 0.98
NFKB1 P19838 1/20 0.98
THPO P40225 1/20 0.98
ABCB11 O95342 1/20 0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxybutynin SCHEMBL5494388 1.00 MEN1 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Aroxybutynin SCHEMBL27093068 1.00 MEN1 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Oxybutynin SCHEMBL8019436 1.00 MEN1 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Oxybutynin SCHEMBL25751 1.00 MEN1 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Oxybutynin SCHEMBL1560964 0.99 CHRM2 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Esoxybutynin SCHEMBL290373 0.99 CHRM2 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Oxybutynin SCHEMBL2992 0.99 CHRM2 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Aroxybutynin SCHEMBL25880 0.99 CHRM2 (1.00) MEN1RECQLPMP22KMT2ANPSR1
Oxybutynin SCHEMBL7557853 0.98 CHRM2 (0.98) MEN1RECQLPMP22KMT2ANPSR1
Oxybutynin SCHEMBL7895841 0.98 CHRM2 (0.98) MEN1RECQLPMP22KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1424321-B1 Synthesis of optically active cyclohexylphenylglycolate esters SEPRACOR INC (US) 2006-07-05 EP disclosed
EP-1642883-A2 Optically active cyclohexylphenylglycolate esters SEPRACOR Inc (US) 2006-04-05 EP disclosed
EP-1424321-A1 Synthesis of optically active cyclohexylphenylglycolate esters Sepracor, Inc. (US) 2004-06-02 EP disclosed
EP-1191930-A2 METHODS FOR TREATMENT OF ASTHMA USING S-OXYBUTYNIN Sepracor Inc. (US) 2002-04-03 EP disclosed
EP-1185498-A2 SYNTHESIS OF OPTICALLY ACTIVE CYCLOHEXYLPHENYLGLYCOLIC ACID AND ITS ESTERS Sepracor Inc. (US) 2002-03-13 EP disclosed
US-6294582-B1 THERAPY OF REVERSIBLE OBSTRUCTIVE PULMONARY DISEASE BY ADMINISTERING OPTICALLY PURE S-OXYBUTYNIN OR ITS SALT SEPRACOR INC. 2001-09-25 US disclosed
WO-2001049267-A1 MULTI-TABLET OXYBUTYNIN SYSTEM FOR TREATING INCONTINENCE OSMOTICA CORP. (VG) 2001-07-12 WO disclosed
US-6248359-B1 SUSTAINED RELEASE LABORATORIOS PHOENIX U.S.A., INC. (AR) 2001-06-19 US disclosed
WO-2000071108-A2 METHODS FOR TREATMENT OF ASTHMA USING S-OXYBUTYNIN SEPRACOR INC. (US) 2000-11-30 WO disclosed
US-6140529-A Synthesis of optically active cyclohexylphenylglycolate esters SEPRACOR INC. (US) 2000-10-31 US disclosed
US-6090971-A Resolution process for cyclohexylphenyl glycolic acid SEPRACOR INC. (US) 2000-07-18 US disclosed
WO-2000023414-A2 SYNTHESIS OF OPTICALLY ACTIVE CYCLOHEXYLPHENYLGLYCOLIC ACID AND ITS ESTERS SEPRACOR INC. (US) 2000-04-27 WO disclosed
US-5973182-A Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters SEPRACOR INC. (US) 1999-10-26 US disclosed